Specialty distributor handle distribution to smaller specialty pharmacies and retail pharmacies.
It is common for each specialty pharmaceutical product to have its own go-to-market strategy. Because of the unique specialty drug product specifications, therapy regimens, drug product handling, storage and transportation requirements, pricing, reimbursement and other factors, drug distribution channels and methodologies are impacted and must be considered prior to product launch. Specialty drugs do not necessarily flow directly downstream to the patient via the dispensing pharmacist. Pharmacy benefit-controlled specialty drugs can be more tightly controlled in real time, improving the payers’ ability to track utilization.
Specialty drugs are produced by specialty pharmaceutical manufacturers then sent to specialty distributors or large specialty pharmacies. From there, they may be distributed directly to patients or be sent to retail pharmacies. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
This report contains market size and forecasts of Specialty Drug Distribution in Global, including the following market information:
Global Specialty Drug Distribution Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Specialty Drug Distribution market was valued at 275360 million in 2021 and is projected to reach US$ 541540 million by 2028, at a CAGR of 10.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oncology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Specialty Drug Distribution include AmerisourceBergen, Mckesson, Cardinal Health, Phoenix, Medipal Holdings, Alliance Healthcare, Sinopharm, Express Scripts and Shanghai Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Specialty Drug Distribution companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Specialty Drug Distribution Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Specialty Drug Distribution Market Segment Percentages, by Type, 2021 (%)
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Others
Global Specialty Drug Distribution Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Specialty Drug Distribution Market Segment Percentages, by Application, 2021 (%)
Hospital and Clinic
Pharmacy
Others
Global Specialty Drug Distribution Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Specialty Drug Distribution Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Specialty Drug Distribution revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Specialty Drug Distribution revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AmerisourceBergen
Mckesson
Cardinal Health
Phoenix
Medipal Holdings
Alliance Healthcare
Sinopharm
Express Scripts
Shanghai Pharma
Anda
Jointown
Max Pharma